A critical review of the literature: Part II: Antibiotic treatment of osteomyelitis in patients with diabetes and foot ulcers

Journal of Wound, Ostomy and Continence Nursing

Volumn 28, Issue 3, 2001, Pages 141-149

  Bonham, Phyllis ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

DIABETIC FOOT; HUMAN; NURSING; OSTEOMYELITIS; REVIEW;

ANTI-BACTERIAL AGENTS; DIABETIC FOOT; HUMANS; OSTEOMYELITIS;

EID: 0035347314     PISSN: 10715754     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjw.2001.114892     Document Type: Article

References (16)

1. Grayson M. Diabetic foot infections-antimicrobial therapy. Infect Dis Clin North Am 1995;9:143-61.
2. Caputo G, Joshi N, Weitek M. Foot infections in patients with diabetes. Am Fam Physician 1997; 56:195-202.
3. Caputo G, Cavanaugh P, Ulbrecht J, Gibbons G, Karchmer A. Assessment and management of foot disease in patients with diabetes. N Engl J Med 1994;331:854-60.
4. Cevera J, Bolton L, Kerstein M. Options for diabetic patients with chronic heel ulcers. J Diabetes Complications 1997;6:358-66.
5. Peterson L, Lissack L, Canter K, Fasching C, Clabots C, Gerding D. Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both. Am J Med 1989;86:801-8.
6. Gentry L, Rodriguez-Gomez G. Ofloxacin versus parenteral therapy for chronic osteomyelitis. Antimicrob Agents Chemother 1991;35:538-41.
7. Lipsky B, Baker P, Landon G, Fernau R. Antibiotic therapy for diabetic foot infections; comparison of two parenteral-to-oral regimens. Clin Infect Dis 1997;24:643-8.
8. Pittet D, Wyssa B, Herter-Clavel C, Kursteiner K, Vaucher J, Lew P. Outcome of diabetic foot infections treated conservatively: a retrospective cohort study with long-term follow-up. Arch Intern Med 1999;159:851-6.
9. Grayson M, Gibbons G, Habershaw G, Freeman D, Pomposelli F, Rosenblum B, et al. Use of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients. Clin Infect Dis 1994;18:683-93.
10. Diamantopoulos E, Haritos D, Yfandi G, Grigoriadou M, Margariti G, Paniara O, et al. Management and outcome of severe diabetic foot infections. Endocrinol Diabetes 1998;106:346-52.
11. Kanellakopoulou K, Giamarellou H. Clinical experience with parenteral and oral ofloxacin in severe infections. Scand J Infect Dis 1990; 68(suppl):64-9.
12. Eron L, Gentry L. Oral ofloxacin for infections caused by bacteria resistant to oral antimicrobial agents. Diagn Microbiol Infect Dis 1992;15:435-9.
13. Galanakis N, Giamarellou H, Moussas T, Dounis E. Chronic osteomyelitis caused by multi-resistant gram-negative bacteria: evaluation of treatment with newer quinolones after prolonged follow-up. J Antimicrob Chemother 1997;39:241-6.
14. Akova M, Ozcebe O, Gullu I, Unal S, Gur D, Akalin S, et al. Efficacy of sulbactam-ampicillin for the treatment of severe diabetic foot infections. J Chemother 1996;8:284-9.
15. Dorigo B, Cameli A, Trapani M, Raspanti D, Torri M, Mosconi G. Efficacy of femoral intra-arterial administration of teicoplanin in gram-positive diabetic foot infections. Angiology 1995;46:1115-22.
16. Guyatt G, Sackett, Cook D. Users' guide to the medical literature: how to use an article about therapy or prevention - are the results of the study valid? JAMA 1993;270:2598-601.